Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

The study concludes that certain domains in Clostridium histolyticum enzymes are structurally unique, bind calcium to become more stable, and play distinct roles in breaking down collagen, with potential applications in medicine and drug delivery.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

Nanotechnology could improve scar treatment but needs more development.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

New hair follicle-targeting treatments show promise for hair disorders but need more research on safety and effectiveness.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

Genomic approach finds new possible treatments for hair loss.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

New materials help control stem cell growth and specialization for medical applications.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

RU58841 significantly increases hair growth rate and initiates more hair cycles, but doesn't affect hair thickness, suggesting it could be a new treatment for baldness.

Scientists developed a new method to deliver alopecia treatment directly to hair follicles, which could be a promising treatment for hair loss and other hair diseases.

Ethosomal carriers effectively deliver hair loss drug into skin.

Microemulsions could improve how drugs are delivered and absorbed in the body.

Higher doses of the medication valproate can cause hair loss, which may stop when the dose is lowered or the medication is stopped.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Berberine may reduce prostate enlargement by blocking inflammation.

The new nanocarriers improve how well water-insoluble drugs dissolve and allow for controlled drug release.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Microneedling is effective for skin rejuvenation and various skin issues, but more research is needed to confirm its safety and effectiveness.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Lipid-polymer hybrid nanoparticles show promise for skin treatments but need better formulation strategies.

Drug repositioning can save time and money but needs more support.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.